Bespoke ExtractsBSPK +8.31%22 3-Year ROIIC % is 15.93 as of Dec. 2024, which is 11% below its 10-year median of 17.92. GuruFocus rates BSPK with a GF Score™ of 22/100 and a GF Value™ of $0.21 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 944 Drug Manufacturers companies, Bespoke Extracts ranks better than 67.16% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Bespoke Extracts's 3-Year ROIIC % for the quarter that ended in Dec. 2024 was 15.93%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Bespoke Extracts's 3-Year ROIIC % or its related term are showing as below:
BSPK's 3-Year ROIIC % is ranked better than 67.16% of 944
companies
in the Drug Manufacturers industry
Industry Median: 3.72
vs BSPK: 15.93
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Bespoke Extracts 3-Year ROIIC % Related Terms
Bespoke Extracts 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Bespoke Extracts's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSPK vs IMCC, NPHC, SKYI: 3-Year ROIIC % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Bespoke Extracts's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bespoke Extracts 3-Year ROIIC % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bespoke Extracts's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Bespoke Extracts's 3-Year ROIIC % falls into.
Bespoke Extracts's 3-Year ROIIC % for the quarter that ended in Dec. 2024 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -0.995 (Dec. 2024) - -0.966 (Aug. 2021) )
/
( 0.355 (Dec. 2024) - 0.537 (Aug. 2021) )
=
-0.029
/
-0.182
=
15.93%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Bespoke Extracts (BSPK) has a 3-Year ROIIC % of 15.93 as of Dec. 2024. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Bespoke Extracts and its competitors. This is 11% below median its historical median of 17.92. According to the industry distribution chart, Bespoke Extracts ranks #310 out of 944 companies in the Drug Manufacturers industry, placing it in the top 32.8%.
Is Bespoke Extracts' 3-Year ROIIC % too high?
Bespoke Extracts' current 3-Year ROIIC % of 15.93 is 11% below median its 10-year median of 17.92. The Drug Manufacturers industry median 3-Year ROIIC % is 3.72. Bespoke Extracts' value of 15.93 is 328.2% above this industry median. Based on the distribution chart, Bespoke Extracts ranks #310 out of 944 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Bespoke Extracts has a GF Score™ of 22/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bespoke Extracts' 3-Year ROIIC % compare to IMCC and NPHC?
According to the Drug Manufacturers industry distribution chart, Bespoke Extracts ranks #310 out of 944 companies for 3-Year ROIIC %. This puts Bespoke Extracts in the upper half of its industry. The industry median 3-Year ROIIC % is 3.72. Bespoke Extracts' value of 15.93 is 328.2% above this benchmark. While the company's 10-year median is 17.92 vs. the industry median of 3.72, Bespoke Extracts has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Drug Manufacturers company?
The median 3-Year ROIIC % among Drug Manufacturers companies is 3.72, based on 944 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bespoke Extracts's current 3-Year ROIIC % of 15.93 is 328.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Bespoke Extracts and its competitors. For the Drug Manufacturers industry, the median 3-Year ROIIC % is 3.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bespoke Extracts's current 3-Year ROIIC % is 15.93, which is 11% below median its own 10-year median of 17.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bespoke Extracts stock overvalued right now?
Based on GuruFocus' analysis, Bespoke Extracts (BSPK) is currently considered Possible Value Trap. The stock's GF Value™ is $0.21, compared to a current price of $0.13 — trading 38% below its estimated fair value. The current 3-Year ROIIC % is 15.93, which is 11% below median its 10-year median of 17.92 and 328.2% above the Drug Manufacturers industry median of 3.72. Bespoke Extracts' overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Bespoke Extracts (BSPK), the current 3-Year ROIIC % is 15.93 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bespoke Extracts (BSPK) Overvalued in 2026?
Based on GuruFocus' analysis, Bespoke Extracts stock appears to be undervalued.
The current stock price of $0.13 is trading 38% below its estimated GF Value™ of $0.21.
GuruFocus considers Bespoke Extracts to be Possible Value Trap.
Key valuation signals for BSPK:
3-Year ROIIC %: 15.93 (11% below median its 10-year median of 17.92)
GF Value™: $0.21 vs. price of $0.13 (38% below fair value)
Industry Position: 328.2% above the Drug Manufacturers median (#310 of 944)
No single metric tells the full story. See the BSPK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, quality, hemp-derived CBD products. The company owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including Fresh Joints, Doobskis, DutchBlunts, and Wee Joints, to licensed marijuana dispensaries across Colorado.
22GF Score
Get the complete analysis for BSPK
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSPK has been successfully added to your 
